Log in
Sign up
Golden has been acquired by ComplyAdvantage.Read about it here ⟶
‌

US Patent 7384967 Aryl carbonyl derivatives as therapeutic agents

Patent 7384967 was granted and assigned to Novo Nordisk on June, 2008 by the United States Patent and Trademark Office.

OverviewStructured DataIssuesContributorsActivity
Is a
Patent
Patent
0
Current Assignee
Novo Nordisk
Novo Nordisk
0
Date Filed
October 6, 2003
0
Date of Patent
June 10, 2008
0
Patent Application Number
10679887
0
Patent Citations Received
‌
US Patent 11944631 Combination therapies
0
‌
US Patent 11974989 Therapeutic uses of glucokinase activators in combination with insulin or insulin analogs
0
‌
US Patent 11939333 Solid forms of isoquinolinones, and process of making, composition comprising, and methods of using the same
0
‌
US Patent 11833136 Therapeutic uses of glucokinase activators in combination with insulin or insulin analogs
0
Patent Inventor Names
Mustafa Guzel
0
Paw Bloch
0
Per Vedso
0
Robert Carl Andrews
0
Janos Tibor Kodra
0
Adnan M. M. Mjalli
0
Anthony Murray
0
Dharma Rao Polisetti
0
Govindan Subramanian
0
Jesper Lau
0
•••
Patent Jurisdiction
United States Patent and Trademark Office
United States Patent and Trademark Office
0
Patent Number
7384967
0
Patent Primary Examiner
‌
Rebecca Anderson
0

Find more entities like US Patent 7384967 Aryl carbonyl derivatives as therapeutic agents

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
Open Query Tool
Access by API
Golden Query Tool
Golden logo
By using this site, you agree to our Terms of Service.